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Dengue viruses (DENVs) are classified into four serotypes, each of which contains multiple genotypes. DENV genotypes in-
troduced into the Americas over the past five decades have exhibited different rates and patterns of spatial dispersal. In or-
der to understand factors underlying these patterns, we utilized a statistical framework that allows for the integration of
ecological, socioeconomic, and air transport mobility data as predictors of viral diffusion while inferring the phylogeo-
graphic history. Predictors describing spatial diffusion based on several covariates were compared using a generalized linear
model approach, where the support for each scenario and its contribution is estimated simultaneously from the data set.
Although different predictors were identified for different serotypes, our analysis suggests that overall diffusion of DENV-1,
-2, and -3 in the Americas was associated with airline traffic. The other significant predictors included human population
size, the geographical distance between countries and between urban centers and the density of people living in urban
environments.
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1. Introduction
Dengue viruses (DENVs), the mosquito-borne etiologic agents of
dengue disease, exist as four serotypes (DENV-1, -2, -3, and -4)
and are endemic in over 100 countries situated primarily be-
tween the Tropics of Cancer and Capricorn. It is estimated that
only about 20 per cent of DENV infections are clinically appar-
ent, of which only a small proportion manifest as life-
threatening severe dengue (Bhatt et al., 2013). Even the milder
form of the disease can be highly debilitating, and with 2.5 bil-
lion people (or roughly 40 per cent of the global human popula-
tion) at risk of infection (World Health Organization, 2009), the
disease burden is very high.
Prior to 1977, only the ‘American subtype’ or Genotype III of
DENV-2 had been documented in the Americas and outbreaks
were sporadic, small and geographically restricted. Successive
introductions of Asian genotypes of each of the four serotypes
from about 1963 onwards precipitated a dramatic change in epi-
demic pattern, initially defined by the occurrence of much
larger and wide spread epidemics, then an increase in incidence
of severe dengue (dengue hemorrhagic fever/dengue shock syn-
drome; Nogueira et al., 1993; Pinheiro and Corber, 1997; Rico-
Hesse et al., 1997; Gubler, 1998b; Carrington et al., 2005), a transi-
tion from hypoendemicity (local establishment and circulation
of one serotype) to hyperendemicity (establishment and circula-
tion of multiple serotypes), and shortening of the intra-
epidemic periods.
Currently, dengue outbreaks occur annually in most tropical
and subtropical countries of the Americas, often involving more
than one serotype (Ramos-Castaneda et al., 2017; Pan American
Health Organization, 2020b). A study conducted by Shephard
et al. (2016) estimated that the aggregate annual total cost of
dengue in the Americas for the period 2000–07 was US$2.1 bil-
lion, the majority of which was associated with productivity
losses induced by non-fatal dengue cases. In 2019, 3.1 million
cases of dengue fever were recorded in the Americas, a 20 per
cent increase from the previous record high in 2015 (Pan
American Health Organization, 2019). Only three of fifty-three
countries and/or territories (i.e. Uruguay, continental Chile and
Canada) are free of endemic DENV transmission (as of 2019; Pan
American Health Organization, 2015, 2019).
The success of dengue in the tropical and subtropical
Americas is a consequence of the widespread prevalence of the
highly anthropophilic vector Aedes aegypti, which thrives in
areas close to human habitation and remains unchecked due to
the inadequacy of mosquito control programs. The very rapid
expansion and establishment of each newly introduced sero-
type was possibly facilitated by rapid human population
growth, socioeconomic changes, uncontrolled urbanization,
and increased ease of human movement at the time. These fac-
tors will surely continue to influence epidemic behavior.
The recent introduction and immense impact of Ae. aegypti-
vectored chikungunya virus (Campion, Weaver, and Lecuit,
2015; Sahadeo et al., 2015, 2017) and Zika virus (Dyer, 2015; Faria
et al., 2016; Fauci & Morens, 2016; Gatherer & Kohl, 2016) on the
Americas highlight the need for a better understanding of the
role of these and other underlying factors in the establishment
and spread of the Ae. aegypti-vectored viruses. In particular, a
better understanding of the patterns of spread of these viruses
is needed to inform monitoring and control strategies and fur-
ther facilitate the development of models that might be used to
predict the behavior of emerging mosquito-borne viruses.
Previous studies have investigated the evolutionary history
and spatial diffusion of DENV (Bennett et al., 2006; Mendez et
al., 2010; Bennett et al., 2010; Nunes et al., 2012; Drumond et al.,
2013). Of these, only a few considered large-scale diffusion (i.e.
amongst countries; Villabona-Arenas & Zanotto, 2011, 2013;
Allicock et al., 2012). Work by Carrington et al. (2005) highlighted
the importance of certain socioeconomic and cultural factors on
the diffusion of the virus in the Americas; however, the relative
lack of genetic information from the Caribbean islands made
such large-scale analyses difficult to interpret (Carrington et al.,
2005). Additionally, previous work from our lab and others have
used various phylogeographic methods for investigating the
movement of DENV (Villabona-Arenas & Zanotto, 2011, 2013;
Allicock et al., 2012) including hypothesis testing (Nunes et al.,
2014). However, no one has used hypothesis testing to investi-
gate the factors driving intra-region viral diffusion over the
Americas.
In this study, we use Bayesian phylogenetic techniques to
reconstruct the long-term region wide transmission dynamics
of individual DENV genotypes in the Americas and identify fac-
tors influencing patterns of spread. The inclusion of a much
larger number of sequences from Caribbean islands (including
fifty-four derived in this study) and the use of a rigorous statisti-
cal framework for hypothesis testing address some of the limi-
tations of previous attempts (Carrington et al., 2005; Allicock
et al., 2012).
2. Materials and methods
2.1 Virus isolation, reverse transcription polymerase
chain reaction amplification, and sequencing
Two sets of confirmed DENV serum samples were collected.
The first set included six DENV-1, nineteen DENV-2, five DENV-
3, and four DENV-4 anonymized serum samples from nine
Caribbean countries, which were obtained from the collection
of the Caribbean Public Health Agency (CARPHA). The second
set included twelve DENV-1 and eight DENV-4 serum samples
collected from Trinidad Public Health Laboratory (TPHL) and
Eric Williams Medical Sciences Complex (EWMSC). Viral RNA
was extracted from 140 ll of serum using QIAamp Viral RNA
Extraction Kits (Qiagen; Valencia, CA). For the first set, envelope
(E) genes were then amplified in a two-step process as described
previously (Allicock et al., 2012).Reverse transcription was per-
formed using SuperScript III Reverse Transcriptase (Invitrogen,
USA) and amplified by polymerase chain reaction (PCR) using
Phusion DNA polymerase (New England Biolabs; Ipswich, MA),
using primers designed for 2 coverage of the entire open read-
ing frame. Primers and thermocycling conditions used were
previously published (Allicock et al., 2012). Amplicons were vi-
sualized on a 2 per cent agarose gel and subsequently excised
and purified using QIAquick Gel Extraction kit (Qiagen;
Valencia, CA). Purified PCR amplicons were sequenced directly
on an Applied Biosystems 3100 genetic analyzer. Sequences
were assembled using Sequencher 4.5 (Gene Codes Corporation;
Ann Arbor, MI) and were submitted to GenBank under the ac-
cession numbers shown in Table 1. For the second set, the
extracted RNA samples were prepared for whole genome se-
quencing. After fragmentation of the RNA, the Illumina TruSeq
RNA Sample Preparation kit v2 (Illumina Inc., San Diego,
California, USA) was used for adapter ligation and amplification
of the libraries, according to manufacturer’s instructions. For
cluster formation of the library templates, the TruSeq PE Cluster
Kit v3 (Illumina Inc., San Diego, California, USA) and the
Illumina cBot workstation were used, also in accordance with
the manufacturer’s instructions. Paired end 50 base sequencing
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Table 1. Dengue envelope gene sequences derived in this study according to year and location of isolation, serotypes, year, and accession
number.
Year Serotype Strain Source Location Accession number
2005 1 510562 CARPHA Belize KU728183
2005 1 511207 CARPHA Belize KU728184
2010 1 1003240 CARPHA Dominica KU728187
2010 1 1003227 CARPHA Dominica KU728186
2010 1 1013169 CARPHA Dominica KU728188
2010 1 510536 CARPHA Belize KU728185
2005 2 514633 CARPHA Suriname KU728189
2005 2 514641 CARPHA Suriname KU728190
2006 2 603616 CARPHA Suriname KU728191
2006 2 609090 CARPHA Suriname KU728192
2006 2 609654 CARPHA Suriname KU728193
2008 2 810812 CARPHA British Virgin Islands KU728201
2008 2 809127 CARPHA St. Lucia KU728199
2008 2 810693 CARPHA British Virgin Islands KU728202
2008 2 809122 CARPHA St. Lucia KU728198
2008 2 807742 CARPHA Trinidad and Tobago KU728194
2008 2 809119 CARPHA St. Lucia KU728197
2008 2 810813 CARPHA British Virgin Islands KU728203
2008 2 808715 CARPHA St. Lucia KU728196
2008 2 810692 CARPHA British Virgin Islands KU728200
2008 2 807832 CARPHA Trinidad and Tobago KU728195
2010 2 1002794 CARPHA Grenada KU728204
2010 2 1003004 CARPHA Grenada KU728207
2010 2 1002795 CARPHA Grenada KU728205
2010 2 1002985 CARPHA St. Vincent and the Grenadines KU728206
2005 3 508133 CARPHA Suriname KU728209
2005 3 508126 CARPHA Suriname KU728208
2005 3 508134 CARPHA Suriname KU728210
2008 3 810432 CARPHA St. Kitts and Nevis KU728211
2008 3 810708 CARPHA St. Kitts and Nevis KU728212
2006 4 609277 CARPHA Dominica KU728213
2006 4 609284 CARPHA Dominica KU728215
2006 4 609282 CARPHA Dominica KU728214
2010 4 1000791 CARPHA Suriname KU728216
2011 1 NSH1108841 TPHL Trinidad and Tobago MN244557
2011 1 NSH1109383 TPHL Trinidad and Tobago MN244560
2011 1 NSH1109147 TPHL Trinidad and Tobago MN244559
2012 1 NSH1204480 TPHL Trinidad and Tobago MN244562
2013 1 NSH1309127 TPHL Trinidad and Tobago MN244565
2013 1 NSH1306199 TPHL Trinidad and Tobago MN244564
2011 1 NSH1109079 TPHL Trinidad and Tobago MN244558
2012 1 NSH1205002 TPHL Trinidad and Tobago MN244563
2012 1 NSH1202573 TPHL Trinidad and Tobago MN244561
2013 1 NSSF260913 TPHL Trinidad and Tobago MN244566
2014 1 NSEW030114 EWMSC Trinidad and Tobago MN244555
2014 1 NSEW060114 EWMSC Trinidad and Tobago MN244556
2012 4 NSH1202583 TPHL Trinidad and Tobago MN244669
2013 4 NSH1300161 TPHL Trinidad and Tobago MN244670
2013 4 NSH1300162 TPHL Trinidad and Tobago MN244671
2013 4 NSH1309045 TPHL Trinidad and Tobago MN244672
2013 4 NSH1309127 TPHL Trinidad and Tobago MN244673
2013 4 NSH1309188 TPHL Trinidad and Tobago MN244674
2014 4 NSH1400093 TPHL Trinidad and Tobago MN244675
2014 4 NSEW310114 EWMSC Trinidad and Tobago MN244668
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was done on the Illumina HiSeq 1000 using the TruSeq SBS kit
v3 (Illumina Inc.; San Diego, California, USA) at the Institute for
Human Infections and Immunity and Department of
Microbiology and Immunology, University of Texas Medical
Branch, Galveston, Texas, USA. Base call conversion to se-
quence reads was performed using CASAVA-1.8.2. Reads were
filtered for quality and adapter sequences were removed.
Contigs were assembled de novo using the AbySS software
(Simpson et al., 2009) which were then checked using bowtie2
(Langmead and Salzberg, 2012), followed by visualization using
the integrative genomics viewer (Robinson et al., 2011). To iden-
tify sequences of viral origin, the assembled contigs were que-
ried against the GenBank/European Molecular Biology
Laboratory Nucleotide Sequence Database/DNA Data Bank of
Japan database using both the Basic Local Alignment Search
Tool (BLAST; Boratyn et al., 2012), both BLASTN and BLASTX
options.
2.2 DENV nucleotide sequence data sets
For each serotype, sequences for the newly generated isolates
(Table 1) were combined with previously published envelope (E)
gene sequences from GenBank. After the removal of sequences
passaged more than three times, or duplicates, the sequences
were aligned using the ClustalW algorithm (Thompson, Higgins,
and Gibson, 1994) as implemented in Geneious 10.1.3 (https://
www.geneious.com), and trimmed to a common length.
Sequence genotypes were confirmed through maximum likeli-
hood tree estimation using a genotype reference alignment
(data not shown). All sequences were confirmed as non-
recombinant using the Recombination Detection Program4 Beta
4.95 (Martin et al., 2015). To avoid over-representation of some
countries, post-sub-sampling was done randomly so that there
were no more than seven sequences per country per year.
Temporal signal was assessed using TempEst v.1.5.3 (Rambaut
et al., 2016). The resulting four data sets, representative of the
main circulating genotypes in the Caribbean, represent thirty-
six countries and a time period covering 1977–2018 (see
Supplementary Table S1 for data set) are summarized in
Table 2.
2.3 Evolutionary and phylogeographic analysis of DENV
To reconstruct the temporal and spatial diffusion of DENV sero-
types in the region, discrete phylogeographic analyses were per-
formed for each of the circulating DENV serotypes. Each taxon
in the data sets was associated with a character state based on
its country/subregion of origin. Subregions were defined by the
CARPHA and the World Health Organization (Pan American
Health Organization, 2020a) for epidemiological reporting pur-
poses, and consider both geographic location and sociohistori-
cal links (see Fig. 1):
• Andean region (AND): Bolivia, Colombia, Ecuador, Peru, and
Venezuela.
• Central America and Mexico (CAM): Belize, Costa Rica, El
Salvador, Honduras, Mexico, Nicaragua, and Panama (note: as
Mexico is the only North American country considered in this
study, for convenience the term Central America is used in refer-
ence to ‘Central America and Mexico’).
• English, French, and Dutch Caribbean (EFD): Antigua and
Barbuda, Aruba, Bahamas, Barbados, British Virgin Islands,
Dominica, French Guiana, Grenada, Guadeloupe, Jamaica,
Martinique, Montserrat, St. Kitts and Nevis, St. Lucia, Suriname,
Trinidad and Tobago.
• Hispanic Caribbean (HIC): Cuba, Dominican Republic, and Puerto
Rico.
• Southern Cone (SAC): Argentina, Brazil, and Paraguay.
Phylogeographic analyses were carried out using a general
time reversible nucleotide substitution model (Tavare et al.,
1997) with four discrete gamma rate categories (Yang, 1996) as
recommended by MODELTEST v3.7 (Posada and Crandall, 1998).
The best fitting coalescent process prior used for DENV-1 was
Bayesian Skyline (Drummond et al., 2005) and for DENV-2 to -4
the Constant (Kingman, 1982) along with an uncorrelated log-
normal clock model (A. J. Drummond and Rambaut, 2007) using
BEAST v1.10.4. software package (Suchard et al., 2018). This se-
lection was based on the estimated marginal likelihood using
Path sampling and stepping stone sampling (Baele, Lemey, and
Vansteelandt, 2013).
To ensure convergence and appropriate effective sampling
sizes for the parameters (> 200), a Markov chain Monte Carlo
was run for 100–150 million generations, with a 10 per cent
burn-in period that was more than adequate to achieve statio-
narity. The program Tracer v1.7.1 (Rambaut et al., 2018) was
used to ensure stationarity was achieved. The software program
TreeAnnotator v1.10.4 was used to summarize the posterior
tree distribution and FigTree v1.4.4. to visualize the annotated
maximum clade credibility (MCC) trees.
2.4 Identifying factors underlying patterns of DENV
diffusion
A generalized linear model (GLM) approach developed as an ex-
tension to the Bayesian inference framework in BEAST frame-
work v1.10.4 (Drummond et al., 2012; Lemey et al., 2012) was
used to test the contributions of potential predictors to spatial
diffusion. The method allows for the reconstruction of phyloge-
netic history and spatiotemporal diffusion (Lemey et al., 2010),
while modeling this diffusion process as a function of a number
of potential predictors for which the support and contribution is
estimated. As support we consider the inclusion probability for
a predictor, which is the posterior expectation of a Boolean indi-
cator variable that determines whether a predictor is included
Table 2. Summary descriptions of DENV E gene data sets.
Serotype Genotype Year range No. of countries represented No. of taxa Sequence size (bp) Positiona
DENV-1 V 1977–2018 21 386 1,485 935–2,419
DENV-2 IIIb 1981–2018 27 452 1,485 937–2,422
DENV-3 III 1994–2017 26 307 1,479 935–2,413
DENV-4 II 1981–2016 20 236 1,485 939–2,423
aBased on reference sequences NC_001477, NC_001474, NC_001475, and NC_002640.
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in or excluded from the model. The contribution is represented
by the effect size (or GLM coefficient) for each predictor on a log
scale. Bayes factors (BFs) were calculated to determine the sup-
port for the inclusion of each predictor in the model, and predic-
tor contributions are reported as effect sizes conditional on the
effect being included in the model.
Predictors investigated fell into the following categories:
i. Distance: Two measures of great-circle distance were used:
• ‘GeoDistance’ represents the log great circle distance be-
tween centroids of each pair of countries.
• ‘PopDistance’ represents log great-circle distance between
the largest and closest population centers between each pair
of countries. Most Caribbean islands only have one main
city. For the larger countries, this was interpreted as the two
closest cities above a certain size relative to the population
size (see Supplementary Table S2 for the locations used).
ii. Airline Passenger Flux: We obtained Data for both of these
predictors from the OAG Max database (http://www.oag.com/)
and represent 1982, 1987, 1992, 1997, 2002, 2007, and 2012.
• Total Air Frequency—total number of flights available be-
tween each pair of countries from the years listed above.
• Total Air Capacity—total number of seats available on flights
between each pair of countries from the years listed above.
iii. Human Population Size (PopSize): We obtained population
size estimates for each country from the Central
Intelligence Agency: The World Factbook (Central
Intelligence Agency, 2014). Origin and destination popula-
tion sizes were included as separate predictors, identified
as ‘Origin PopSize’ and ‘Destination PopSize’, respectively.
iv. Level of Urbanization: We obtained data from the United
Nations Development Programme: Human Development
Reports (2014) which looked at two different predictors re-
lated to urbanization.
• The percentage of the population of a given country living in
urban areas between a pair of locations (United Nations
Development Programme, 2014a). These data rely on na-
tional definitions for what constitutes a city or metropolitan
area. These were included as the predictors ‘origin urbaniza-
tion (%)’ and ‘destination urbanization (%)’.
• A calculation of the percentage of total land area covered
by forests in a given country in 2012. These were included
as separate predictors, ‘Origin Forest’ and ‘Destination Forest’.
Figure 1. Map of the Americas. Location of the countries included in the study, from South America, the Caribbean, and Central America.
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v. Level of Human Development: We obtained data from
United Nations Development Programme: Human
Development Reports (United Nations Development
Programme, 2014b) for the Human Development Index
(HDI). These were included as separate predictors, ‘Origin
HDI’ and ‘Destination HDI’.
vi. Sample size: To assess the impact of heterogeneous sam-
pling, we included the number of sequences between each
pair of countries as a predictor. These data were included
as separate predictors, ‘Origin Sample Size’ and
‘Destination Sample Size’.
3. Results
3.1 Evolutionary history and phylogeography of DENV-1
to -4 in the Americas
Figures 2–5 show the MCC phylogenies inferred from the four
data sets in which sequences were tagged according to the
country from which they originated. The estimated DENV phy-
logenies demonstrate spatial subdivision to different degrees,
as evidenced by the clustering of sequences into well-supported
clades defined by country. This spatial subdivision was more
evident at the subregional level (Supplementary Figs. S1–4). The
inferred rates of evolution can be seen in Table 3.
The DENV-1 (Genotype V) phylogeny (Fig. 2) The basal clade
is comprised of older sequences from Grenada, Trinidad and
Tobago and Barbados (EFD), Puerto Rico (PR a), and Mexico (MX
a) which circulated from 1977 to 2000. It also includes a mono-
phyletic lineage comprised of newer sequences from Brazil (BR
a, 2002–13), along with three sequences from Argentina and one
sequence from the British Virgin Islands.
The majority of the other sequences clustered together in
the second major monophyletic clade, with sequences from
Grenada, the Bahamas, Suriname, French Guiana and Trinidad
and Tobago (EFD) falling in the basal position. This clade also
includes sequences from Brazil (BR b), Venezuela, Colombia,
Figure 2. Bayesian MCC tree summarized for the DENV-1 Genotype V data set (n¼386). Terminal branches are colored according to the location of origin of the se-
quence at the tip, with colors as indicated in the key. Likewise, internal branches are colored according to the most probable (modal) location of their parental node in-
ferred using a discrete phylogeographic diffusion model. Posterior clade probability percentages for nodes > 0.90 are indicated by black nodes. Location abbreviations
are as follows: ANT, Antigua & Barbuda; ARG, Argentina; ARU, Aruba; BAH, Bahamas; BAR, Barbados; VG, British Virgin Islands; BEL, Belize; BOL, Bolivia; BRA, Brazil;
COL, Colombia; CR, Costa Rica; DR, Dominican Republic; DOM, Dominica; ECU, Ecuador; FGA, French Guiana; GRE, Grenada; GUY, Guyana; GUA, Guadeloupe; HON,
Honduras; JAM, Jamaica; MAR, Martinique; MON, Montserrat; MEX, Mexico; NIC, Nicaragua; PAR, Paraguay; PR, Puerto Rico; PAN, Panama; SAL, El Salvador; SKN, St.
Kitts & Nevis; SLU, St. Lucia; SVG, St. Vincent & the Grenadines; SUR, Suriname; TT, Trinidad & Tobago; VEN, Venezuela.
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and Nicaragua. Newer sequences from Trinidad and Tobago,
Dominica and Barbados were found dispersed throughout a
large monophyletic grouping, comprising mostly of Colombian
and Venezuelan sequences (AND). There is evidence of co-
circulation of distinct lineages, with one lineage persisting and
expanding, whereas the other becomes extinct (posterior proba-
bility > 0.90 at the internal node) in some countries, for exam-
ple, Grenada in 1977–81 (labeled as GREa and GREb in Fig. 2),
Puerto Rico during 1992–96 (PRa and PRb), suggesting multiple
introductions of this genotype into several of these countries.
Countries from EFD were basal in this phylogeny, indicative
of more gene flow from this subregion upon introduction
around 1973 (95% HPD 1972–75). The overall pattern of this phy-
logeny is characterized by clear subdivision by subregion, with
initial DENV-1 diffusion from the Caribbean islands (EFD and/or
HIC, which I will refer to as ‘island’) to the South and/or Central
America (SAC, AND, CAM, which I will refer to as ‘mainland’),
which then acted as an occasional source of gene flow back to
the islands. Based on estimated root state probabilities, the
most recent common ancestor for the DENV-1 sequences repre-
sented in the data set is estimated to have existed in Grenada
(root state probability ¼ 0.98 versus the Bahamas (0.01)).
In the DENV-2 (Genotype IIIb) phylogeny (see Fig. 3), sequen-
ces sampled from the first outbreak in Jamaica, Suriname, and
Barbados (EFD) fell in the basal position, with all but one of the
sequences represented were sampled 1981–87. Within this
grouping there were also sequences from Trinidad and Tobago
sampled 1986–96, indicating that this lineage persisted in
the EFD for at least 14 years before extinction. There is
evidence of multiple distinct lineages co-circulating in a
country, one of which persists and expands, while the other
becomes extinct. The more obvious examples include Puerto
Rico (PRa and PRb), Trinidad and Tobago (EFD clades)
and Brazil (BRa, BRb, and BRc). Like DENV-1, the most recent
Figure 3. Bayesian MCC tree summarized for the DENV-2 Genotype IIIb data set (n¼452). Terminal branches are colored according to the location of origin of the se-
quence at the tip, with colors as indicated in the key. Likewise, internal branches are colored according to the most probable (modal) location of their parental node in-
ferred using a discrete phylogeographic diffusion model. Posterior clade probability percentages for nodes > 0.90 are indicated by black nodes. Location abbreviations
are as follows: ANT, Antigua & Barbuda; ARG, Argentina; ARU, Aruba; BAH, Bahamas; BAR, Barbados; BVI, British Virgin Islands; BEL, Belize; BOL, Bolivia; BRA, Brazil;
COL, Colombia; CR, Costa Rica; DR, Dominican Republic; DOM, Dominica; ECU, Ecuador; FGA, French Guiana; GRE, Grenada; GUY, Guyana; GUA, Guadeloupe; HON,
Honduras; JAM- Jamaica; MAR, Martinique; MON, Montserrat; MEX, Mexico; NIC, Nicaragua; PAR, Paraguay; PR, Puerto Rico; PAN, Panama; SAL, El Salvador; SKN, St.
Kitts & Nevis; SLU, St. Lucia; SVG, St. Vincent & the Grenadines; SUR, Suriname; TT, Trinidad & Tobago; VEN, Venezuela.
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common was estimated to have existed in EFD, represented by
Jamaica or Suriname (root state probability ¼ 0.52 and 0.44) in
1975 (95% HPD 1970–78). The topology of the phylogeny exhib-
ited patterns of spatial subdivision, as the sequences clustered
based on location at the subregion (see Supplementary Fig. S2)
and country levels.
The DENV-3 (Genotype III; see Fig. 4) phylogeny is separated
into two monophyletic clades based on posterior probability (I
and II), which are estimated to have arisen from a common an-
cestor that existed in Nicaragua (root state probability ¼ 0.74,
Venezuela ¼ 0.10) in 1982 (95% HPD 1975–88). The basal position
of the phylogeny is comprised of sequences from the original
outbreak in Panama and surrounding countries (CAM) along
with sequences from Mexico, Venezuela, and Colombia. This
clade also included five sequences from St. Kitts and Nevis,
Jamaica and Grenada, likely due to one-off introductions of this
strain to these countries. Co-circulation of the difference
lineages were observed in Puerto Rico between 1999 and 2006
(PRa and PRb) and Colombia from 2004 to 2007 (COLa and COLb).
The majority of the other EFD sequences were located in one
well-supported grouping.
The topology of the MCC phylogeny for DENV-4 Genotype II
(see Fig. 5) revealed a temporal pattern, unlike the other sero-
types. This genotype circulating in this region is estimated to
have diverged from a common ancestor that existed in 1976
(95% HPD 1972–80) located in Puerto Rico (root state probability
¼ 0.79). The base of the phylogeny is comprised of sequences
from all subregions, mostly from CAM (Honduras, Mexico, and
El Salvador) and EFD (Trinidad and Tobago, Jamaica, Suriname,
and Dominica), sampled between 1981 and 2000. The next clade
is comprised of sequences from Puerto Rico, where this lineage
persisted for 29 years (1985–2014) with sporadic introductions to
various EFD islands. This genotype then spread to the AND in
1995, then was reintroduced to the SAC in 2011.
Figure 4. Bayesian MCC tree summarized for the DENV-3 Genotype III data set (n¼307). Terminal branches are colored according to the location of origin of the se-
quence at the tip, with colors as indicated in the key. Likewise, internal branches are colored according to the most probable (modal) location of their parental node in-
ferred using a discrete phylogeographic diffusion model. Posterior clade probability percentages for nodes >0.90 are indicated by black nodes. Location abbreviations
are as follows: ANT, Antigua & Barbuda; ARG, Argentina; ARU, Aruba; BAH, Bahamas; BAR, Barbados; BVI, British Virgin Islands; BEL, Belize; BOL, Bolivia; BRA, Brazil;
COL, Colombia; CR, Costa Rica; DR, Dominican Republic; DOM, Dominica; ECU, Ecuador; FGA, French Guiana; GRE, Grenada; GUY, Guyana; GUA, Guadeloupe; HON,
Honduras; JAM, Jamaica; MAR, Martinique; MON, Montserrat; MEX, Mexico; NIC, Nicaragua; PAR, Paraguay; PR, Puerto Rico; PAN, Panama; SAL, El Salvador; SKN, St.
Kitts & Nevis; SLU, St. Lucia; SVG, St. Vincent & the Grenadines; SUR, Suriname; TT, Trinidad & Tobago; VEN, Venezuela.
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Figure 5. Bayesian MCC tree summarized for DENV-4 Genotype II data set (n¼ 236). Terminal branches are colored according to the location of origin of the sequence at
the tip, with colors as indicated in the key. Likewise, internal branches are colored according to the most probable (modal) location of their parental node inferred using
a discrete phylogeographic diffusion model. Posterior clade probability percentages for nodes > 0.90 are indicated by black nodes. Location abbreviations are as follows:
ANT, Antigua & Barbuda; ARG, Argentina; ARU, Aruba; BAH, Bahamas; BAR, Barbados; BVI, British Virgin Islands; BEL, Belize; BOL, Bolivia; BRA, Brazil; COL, Colombia;
CR, Costa Rica; DR, Dominican Republic; DOM, Dominica; ECU, Ecuador; FGA, French Guiana; GRE, Grenada; GUY, Guyana; GUA, Guadeloupe; HON, Honduras; JAM,
Jamaica; MAR, Martinique; MON, Montserrat; MEX, Mexico; NIC, Nicaragua; PAR, Paraguay; PR, Puerto Rico; PAN, Panama; SAL, El Salvador; SKN, St. Kitts & Nevis; SLU,
St. Lucia; SVG, St. Vincent & the Grenadines; SUR, Suriname; TT, Trinidad & Tobago; VEN, Venezuela.
Table 3. Rates of nucleotide substitution, location, and year the most recent ancestor existed for DENV-1 to -4 data sets.
DENV serotype
(genotype)
Mean rate of nucleotide substitution/site/year MRCAa (year) Root state location
(posterior probability)
Mean 95% HPDb Mean 95% HPDb
1 (V) 7.17  104 6.39  104, 8.02  104 1973 1972–75 Grenada (0.98)
2 (IIIb) 8.14  104 7.24  104, 8.98  104 1975 1970–78 Jamaica (0.52)
3 (III) 8.24  104 7.09  104, 9.44  104 1982 1975–88 Nicaragua (0.74)
4 (II) 1.09  103 9.52  104, 1.24  103 1976 1972–80 Puerto Rico (0.79)
aMost recent common ancestor.
bHighest probability density.
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3.2 Factors underlying patterns of DENV diffusion
We compared nine potential predictors of DENV diffusion using
a GLM approach, with the results summarized in Fig. 6.
Predictors were identified as significant based on the BF sup-
port, where BF > 3¼positive, >20¼ strong, and >150 very
strong. None of the predictors contributed to the spatial diffu-
sion of DENV-4 in the region and as such will not be discussed
further. Overall, there was consistent and overwhelming sup-
port for the frequency of flights driving the rate of spatial diffu-
sion of the virus in the Americas for DENV-1, DENV-2, and
DENV-3 (gene flow and AirFrequency are positively correlated;
BFs  999 with positive mean conditional effect size). The num-
ber of airline seats (Total Air Capacity) was also included as a
predictor for DENV-2.
Other than AirFrequency, the predictors contributing to the
gene flow differed across the serotypes. Distance (GeoDistance)
was identified as a significant predictor for DENV-1 and -3 with
a negative effect size, indicating more intense diffusion among
countries that are in close proximity. In the case of population
size, the intensity of gene flow was positively correlated with
the population size of the country of origin. Population size was
identified as a predictor for DENV-1 and -3, with more gene flow
into countries with larger populations, and for DENV-3, both
from and to larger populations. The percentage of the popula-
tion living in urban populations in the origin country was nega-
tively correlated with gene flow, indicating that gene flow is
more intense from less urbanized countries for DENV-2. The
number of location transitions estimated using the DENV-2
data set was influenced by the sample size for the countries of
origin, indicating that sample size may play a role in the inclu-
sion/exclusion of the other predictors (Lemey et al., 2014).
4. Discussion
The invasion of the Americas by DENV serotypes and/or geno-
types that were previously unknown in the region is well docu-
mented (Pinheiro & Corber, 1997; Rico-Hesse et al., 1997; Gubler,
1998b; Carrington et al., 2005; Bennett et al., 2010; Mendez et al.,
2010). The genotypes of DENV-1 to -4 analyzed in this study
have now been in the region for 26–43 years (depending on the
serotype) and were the most prevalent during the time period
represented by the data sets used in this study. Other genotypes
have circulated in the Caribbean (DENV-2 IIIb and V; Foster
et al., 2004); however this phenomenon is observed more in the
larger countries (DENV-II Genotypes I and III in Brazil; Vilela
et al., 2010and DENV-3 Genotypes III and V in Columbia and
Brazil among others; Aquino et al., 2009; Mendez et al., 2010).
Although evidence suggests that DENV-1, -2, and -4 entered
the Americas via the Caribbean islands (Pan American Health
Organization, 1979; Gubler, 1998a; Kouri et al., 1989), both epide-
miological data and our GLM analysis indicate that DENV-3 was
introduced to the region via the mainland (South or Central
America; Centers for Disease Control and Prevention, 1995). The
contribution of larger population sizes to gene flow both in the
origin and destination of the virus also supports the introduc-
tion of DENV-3 Genotype III via the mainland. The larger human
populations on the mainland and comparatively unhindered
gene flow (i.e. compared with movement among islands, where
the sea presents a physical barrier), may account for the more
explosive outbreak than observed for the other serotypes.
The DENV-1, -2, and -3 phylogenies have similar topologies,
characterized by the co-circulation of different lineages in some
countries like Puerto Rico, Venezuela, and spatial subdivision.
The extent of spatial subdivision is more evident when sequen-
ces were assigned to subregions (which consider both
Figure 6. Predictors of DENV-1 to -4 diffusion. The contribution of each predictor (i.e. the conditional effect size) when included in the model (bjd ¼ 1), is represented by
the mean and credible intervals of the GLM coefficients on a log scale. Inclusion probabilities are represented as BFs (BF > 3¼positive, >20¼ strong, >150 very strong).
Posterior mean and 95% Bayesian credible interval are represented as a black dot and line respectively. Another probability measure of inclusion or exclusion of the
predictor is represented by indicator variable d (rightmost panel).
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geography and historical links) than when assigned to coun-
tries. It is however possible that the longer persistence of line-
ages in these countries compared with others are artifacts
reflecting the more thorough surveillance systems and se-
quencing efforts (Gubler, 1987).
Air traffic, and more specifically the number of scheduled
flights between countries, was identified as a major determi-
nant of DENV diffusion (except in the case of DENV-4, for which
none of the predictors was significant). The importance of air
transportation is not surprising given that the distances be-
tween Caribbean islands, and between the islands and the
mainland, are well beyond the range of the vector, and that air
travel is the main mechanism for human movement between
islands. Interestingly, the number of scheduled flights was the
predictor and not the total number of available seats. This is
consistent with our previous study (Allicock et al., 2012), where
only seat capacity was used as a proxy for air traffic and no cor-
relation was found. Nunes et al. (2014) also found that the num-
ber of scheduled flights between regions within Brazil was a
predictor of DENV diffusion but did not consider seat capacity.
Tian et al. (2017) identified the contribution of air travel to the
diffusion of the DENV using passenger flow data. One explana-
tion for the failure of total seat capacity to predict gene flow in
our DENV-1 and -3 data sets is that airplanes do not always fly
at full capacity. Also, seat capacity gives an indication of the to-
tal number of humans sampled from a country, whereas the
frequency of flights relates to how often the human population
is sampled. Since DENV is seasonal (incidence is much higher
during the rainy season months) and may be absent in a given
country in a given year, an air traffic model that reflects the fre-
quency at which a given country is sampled (Total Air
Frequency) might reasonably be expected to outperform one
that reflects the size of the sample (Total Air Capacity).
Distance between countries was identified as a predictor of
intensity of DENV diffusion between pairs of countries for
DENV-1 and -3 with more intense gene flow between nearby
countries. This was the case when proximity was represented
by the distances between the centroids of countries but not
when the distances between nearby large population centers
were used. The latter (PopDistance predictor) was included in
recognition of the fact that the human populations are not
evenly distributed within countries; however, it was not a con-
tributor. Other geographic heterogeneity (mountain regions, riv-
ers, etc.) and cultural confounders can affect the success of this
predictor, but these were not taken into account. This meant
that the closest and largest population centers between two
countries of the Americas might be an unsuitable predictor be-
tween certain countries, especially on the mainland, and be-
tween HIC and other Caribbean Islands. GeoDistance may
therefore be the better predictor because it effectively averages
across these heterogeneities.
Human population size was identified as an important
driver of DENV-1 and -3 diffusion. For DENV-1 the population
size of the origin country. More intense gene flow into larger
populations is consistent with a gravity model where larger
populations act as ‘sinks’ for DENV from smaller populations.
DENV-1 was first introduced to a Caribbean island (with a small
population) which had stronger connections to other island
states (EFD) than to the mainland countries where populations
are much larger. This gravity model of DENV diffusion is also
evident by the inverse relationship between rate of diffusion
and the level of urbanization of origin countries observed for
DENV-2.
The four DENV serotypes all use the same human host and
Ae. aegypti vector so two obvious questions arising from this
study are 1) why were no predictors identified for DENV-4 and
2) why (with the exception of air traffic) were the same predic-
tors not consistently identified across the other three sero-
types? An important difference between the DENV-4 data set
and those for the other serotypes is the predominance of Puerto
Rican sequences. The number of sequences available varied
widely across the countries within this region. To avoid under-
representing or over-representing discrete locations, post-sub-
sampling was necessary (Lemey et al., 2012; Magee and Scotch,
2018) so the number of samples for each country was limited to
no more than seven per year. However, the number of years in
which Puerto Rico is represented in the DENV-4 data set (n¼ 16)
is higher than for other countries (n¼ 1–8), which meant that
within-country dynamics may not have been sampled for some
countries and any inferences may be influenced by this
imbalance.
With regards to the variation among DENV-1, -2, and -3 pre-
dictors, the overall diffusion pattern described by each serotype
might be strongly influenced by the environment into which
each virus was first introduced (e.g. a small, comparably iso-
lated, island population versus a larger, mainland population
with road links to neighboring countries), as well as the im-
mune landscape at that location at the time of introduction and
at each subsequent destination. DENV infection with a given se-
rotype gives rise to high-titer neutralizing antibodies that confer
life-long immunity to the infecting serotype, immunity to other
serotypes is short-lived (Reich et al., 2013), which adds to the
complexity of the immune landscape. Additionally, sub-
neutralizing antibodies arising from an infection can enhance
subsequent heterotypic DENV infections (Dejnirattisai et al.,
2010) and there is evidence that antibodies arising from infec-
tion with closely related flaviviruses (e.g. Zika virus) may modu-
late DENV infection (Calisher et al., 1989). Thus, at any given
time, the prevalence and type of immunity at each location
would have been shaped by which serotypes were previously in
circulation at that location and the length of time since the last
outbreak.
The data informing the priors used (airline traffic, popula-
tion size, etc.) are an important limitation to of the hypothesis
testing analyses. These data were selected from a single-time
point, while the genetic data spanned 26–43 years depending on
the serotype. This would of course only affect those proxies that
change over time (For example, distance would be unaffected).
The impact would also be dependent on the magnitude of
change during the time frame under investigation. For example,
while human population size, urban densities, per cent forested
areas, and HDI might be relatively stable or change very gradu-
ally, airline traffic has changed significantly, both in frequency
and the connectivity between countries. Future studies can in-
clude the utilization of the epoch model (Goode et al., 2008;
Bielejec et al., 2014 in the investigation of diffusion factors, as it
allows different rate matrices to be specified for different time
periods.
In conclusion, the strongest and most consistent predictor
for rates of DENV movement between pairs of countries within
the Americas is the frequency of air traffic between those coun-
tries. Human population size, the distance between these coun-
tries, the percentage of people living in urban environments
and HDI were also predictive but were not consistent across
serotypes and may reflect complex interactions among predic-
tors and/or location-specific conditions not captured by the pre-
dictors tested.






/ve/article/6/2/veaa074/5917031 by guest on 03 February 2021
Data availability
All sequences derived in this study are available at GenBank ac-
cession numbers KU728183–KU728216 and MN244555–
MN244675. Phylogenetic MCC tree files are available at doi:
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